
ABT Valuation
Abbott Laboratories
- Overview
- Forecast
- Valuation
- Earnings
ABT Relative Valuation
ABT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABT is overvalued; if below, it's undervalued.
Historical Valuation
Abbott Laboratories (ABT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 23.23 is considered Undervalued compared with the five-year average of 24.69. The fair price of Abbott Laboratories (ABT) is between 136.43 to 155.52 according to relative valuation methord. Compared to the current price of 125.64 USD , Abbott Laboratories is Undervalued By 7.91%.
Relative Value
Fair Zone
136.43-155.52
Current Price:125.64
7.91%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
4.51
P/B
Median3y
4.92
Median5y
5.42
0.00
FCF Yield
Median3y
3.06
Median5y
3.24
Competitors Valuation Multiple
The average P/S ratio for ABT's competitors is 7.51, providing a benchmark for relative valuation. Abbott Laboratories Corp (ABT) exhibits a P/S ratio of 4.71, which is -37.37% above the industry average. Given its robust revenue growth of 7.37%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

LIN
Linde PLC
472.890
USD
+0.30%

SHEL
Shell PLC
71.990
USD
-0.54%

HSBC
HSBC Holdings PLC
64.920
USD
-0.09%

INTU
Intuit Inc
785.950
USD
+0.61%

GE
General Electric Co
271.590
USD
+1.34%

RY
Royal Bank of Canada
132.050
USD
+0.02%

QCOM
Qualcomm Inc
158.400
USD
-0.28%

CAT
Caterpillar Inc
433.750
USD
+0.98%

VZ
Verizon Communications Inc
43.080
USD
0.00%

TXN
Texas Instruments Inc
184.990
USD
-0.38%
FAQ

Is Abbott Laboratories (ABT) currently overvalued or undervalued?
Abbott Laboratories (ABT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 23.23 is considered Undervalued compared with the five-year average of 24.69. The fair price of Abbott Laboratories (ABT) is between 136.43 to 155.52 according to relative valuation methord. Compared to the current price of 125.64 USD , Abbott Laboratories is Undervalued By 7.91% .

What is Abbott Laboratories (ABT) fair value?

How does ABT's valuation metrics compare to the industry average?

What is the current P/B ratio for Abbott Laboratories (ABT) as of Jul 25 2025?

What is the current FCF Yield for Abbott Laboratories (ABT) as of Jul 25 2025?

What is the current Forward P/E ratio for Abbott Laboratories (ABT) as of Jul 25 2025?
